SENSEX NIFTY

Q4

Aug 21, 2014 at 15:17 | Source: CNBC-TV18
In an interview to CNBC-TV18s Anuj Singhal and Sonia Shenoy, Arpit Vyas, Managing Director of Dishman Pharma spoke about the latest happenings in the company and the road ahead.
Aug 13, 2014 at 10:16 | Source: PTI
Net sales of the company rose to Rs 476.67 crore for the fourth quarter, as compared to Rs 392.07 crore in the same period of previous fiscal.
Aug 11, 2014 at 16:21 | Source: CNBC-TV18
Tata Motor's consolidated net profit rose more than three-fold (212.7 percent) to Rs 5,398 crore driven by strong Jaguar Land Rover (JLR) performance.
Aug 07, 2014 at 22:12 | Source: CNBC-TV18
Analysts believe the asset quality of the bank may be contained (similar improvement like Q4FY14) due to selling of loans to asset reconstruction companies, upgrades and recoveries during the quarter.
Aug 07, 2014 at 15:22 | Source: Moneycontrol.com
Operating profit slipped 17 percent on yearly basis to Rs 160 crore in the first quarter of current financial year 2014-15 and margin dropped 260 basis points year-on-year to 13 percent in the quarter gone by but that improved by 360 bps sequentially from 10.6 percent in Q4FY14.
Aug 07, 2014 at 14:44 | Source: CNBC-TV18
Same-store-sales (SSS) growth contracted at 2.4 percent in the first quarter of current financial year 2014-15 compared to 6.3 percent growth in same quarter last year. SSS growth has been in negative for the third consecutive quarter followed by negative 3.4 percent in Q4FY14 and negative 2.6 percent in Q3FY14.
Aug 04, 2014 at 12:01 | Source: Moneycontrol.com
After two quarters of operating profits, Indias leading wind turbine maker Suzlon expects to turn the corner by the fourth quarter of FY15 and to reduce some of interest cost also by capital structure optimisations.
Aug 04, 2014 at 10:27 | Source: CNBC-TV18
Srei Infrastructure Finance's consolidated operating profit for the quarter stood at Rs 265.03 crore against Rs 137.24 crore in the same quarter a year ago.
Jul 31, 2014 at 18:08 | Source: CNBC-TV18
Asset quality will also be closely watched as it deteriorated in previous quarter. Slippages and restructured loans continued to remain elevated. The restructured pipeline was Rs 1,700 crore at the end of March 2014 with gross non-performing assets (GNPA) guidance at 3.75 percent as against 4.08 percent in Q4FY14.
Jul 31, 2014 at 16:45 | Source: PTI
Symphony's net sales in the quarter under review stood at Rs 150.63 crore, up 35.49 percent as against Rs 111.17 crore in the same period last year.
Messages on Q4 »

bvijaaaa576

New Member

0 Follower

Aurobindo Pharm  

golden chance to buy at this level. Q4 results are very strong . Target before results 1000.

3.06 PM Jul 8th

shmarketgen
ius

Platinum Member

409 Followers

Hinduja Global  

Q4 was not upto the mark,but for full FY14,HGS has managed to increase its revenues by a healthy 26%.This was accompanied by a near 90% rise in EPS.I see no reason,why 20-25% growth should be a problem.The Phillipines business will also pick up this year & beyond.

11.21 AM Jul 8th

lcm

New Member

6 Followers

Neo Corp Inter  

Q4 base was 9,now Q1 base is 15 next base at 26 plus.buy and keep patience.

10.03 AM Jul 8th

niru to help

Platinum Member

391 Followers

Visesh Infotech  

to declare Q4 results which i don`t know what they have given. Hence, it will not get delisted. And my target of 3 months is between Rs 2-3. It can be more than that.

11.59 PM Jul 7th

follower

Gold Member

20 Followers

Astec Life  

Dear unseenvalue, what kind of growth prospects does the Company management envisage in next 6-12 months. The growth in latest Q4 2014 was not very good. Though operating margin is comparable to Industry players like Dhanuka etc, the return on net worth / ROCE is on lower side. The Company has

11.48 PM Jul 7th

setu74

Silver Member

2 Followers

Alembic Pharmaceuticals  

quarterly result will be soft post Q4 dumping. Performance will improve over Q2 and Q3. Sell at 305 and buy at 285 post results

2.48 PM Jul 7th

follower

Gold Member

20 Followers

Genus Power  

margin (OPM) however, dipped in the last (Q4 of FY 2015) quarter from 14.3% to 8.7%. They are one of the prominent players in the electrical metering and allied equipment segment.Please share if you have any information. warm regards!

1.30 PM Jul 7th

follower

Gold Member

20 Followers

Asahi Songwon  

.4 Q4 2014 Vinati: 22.2 / 23.3 RONW: Aarti: 22.1; Vinati: 32.1 Disc: I hold Asahi Songwon. warm regards!

8.50 PM Jul 6th

kanakbhai

Gold Member

44 Followers

RS Software  

and visibility of multiyear earning and also increasing dividend year after year.The answer to the second question is the RS Software has been unfairly treated by the market over it`s peers even after Q3/Q4 2014 results.Here is the real catch,when such a unfair valuation is given by market, means it is made

8.18 PM Jul 5th

akkirathore

Silver Member

2 Followers

PC Jeweller  

after q4 results. 96-105-92-120 10.35 AM Mar 22nd

9.46 PM Jul 4th

News across the web »
Aug 05, 2014 at 04:32 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.